In the mid-term perspective (3-5 years after the end of the project), B-Trust is expected to:

Increase public acceptance of biotechnologies through the co-creation programme and guidelines, which will result in funding and biotechnological developments increase.

Contribute to Europe’s economic growth in biotechnology, aiming to maintain and drive Europe’s annual growth rate of 4.1%.

Engage with over 250 advisors and policymakers at national, regional, and EU levels, 5000 SMEs/researchers, 50 representative organisations in biotechnology, and 100 civil society and consumer groups, accelerating advancements in biotechnology.

Enhance biotechnology literacy among European citizens, companies in the agri-food and bio-based industries, and public authorities, enabling effective response to new biotechnologies by balancing risks and rewards.

Influence individual attitudes toward biotechnology, shaping public dialogue, societal norms, and regulations, impacting the pace and extent of adoption.

Contribute to significant sustainable development impacts in areas such as SDG2 Zero Hunger, SDG3 Good Health and Well-being, SDG 7 Affordable and Clean Energy, and SDG 12 Responsible Consumption and Production.

Enhance policy coherence for sustainable development and macro-economic stability in biotechnology.